Stanko RT, Mullick P, Clarke MR, et al. Pyruvate inhibits growth of mammary adenocarcinoma 13762 in rats. Cancer Res 1994;54:1004-7.
Stanko RT, Robertson RJ, Galbreath RW, et al. Enhanced leg exercise endurance with a high-carbohydrate diet and dihydroxyacetone and pyruvate. J Appl Physiol 1990;69:1651-6.
Stanko RT, Robertson RJ, Spina RJ, et al. Enhancement of arm exercise endurance capacity with dihydroxyacetone and pyruvate. J Appl Physiol 1990;68:119-24.
Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization, and nitrogen metabolism with a 4.25-MJ/d low-energy diet supplemented with pyruvate. Am J Clin Nutr 1992;56:630-5.
Matthys D, Van Coster R, Verhaaren H. Fatal outcome of pyruvate loading test in child with restrictive cardiomyopathy. Lancet 1991;338:1020-1.
Stanko RT, Reynolds HR, Hoyson R, et al. Pyruvate supplementation of a low-cholesterol, low-fat diet: effects on plasma lipid concentrations and body composition in hyperlipidemic patients. Am J Clin Nutr 1994;59:423-7.
Ivy JL, Cortez MY, Chandler RM, et al. Effects of pyruvate on the metabolism and insulin resistance of obese Zucker rats. Am J Clin Nutr 1994;59:331-7.
DeBoer LW, Bekx PA, Han L, Steinke L. Pyruvate enhances recovery of rat hearts after ischemia and reperfusion by preventing free radical generation. Am J Physiol 1993;265:H1571-6.
Gheresitich I, Brazzini B, Perris K, et al. Pyruvic acid peels for the treatment of photoaging. Dermatol Surg 2004;30:32-6.
Kalman D, Colker CM, Wilets I, et al. The effects of pyruvate supplementation on body composition in overweight individuals. Nutrition 1999;15:337-40.
Koh-Banerjee PK, Ferreira MP, Greenwood M, et al. Effects of calcium pyruvate supplementation during training on body composition, exercise capacity, and metabolic responses to exercise. Nutrition 2005;21:312-9. .
Stone MH, Sanborn K, Smith LL, et al. Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players. Int J Sport Nutr 1999;9:146-65. .
Van Schuylenbergh R, Van Leemputte M, Hespel P. Effects of oral creatine-pyruvate supplementation in cycling performance. Int J Sports Med 2003;24:144-50.
Vierck JL, Icenoggle DL, Bucci L, Dodson MV. The effects of ergogenic compounds on myogenic satellite cells. Med Sci Sports Exerc 2003;35:769-76.
Ferrando, J. [Clinical trial of a topical preparation containing urea, sunflower oil, evening primrose oil, wheat germ oil and sodium pyruvate, in several hyperkeratotic skin conditions]. Med Cutan.Ibero.Lat.Am 1986;14(2):133-137.
Hermann, H. P., Pieske, B., Schwarzmuller, E., Keul, J., Just, H., and Hasenfuss, G. Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study. Lancet 4-17-1999;353(9161):1321-1323.
Devamanoharan, P. S., Henein, M., Ali, A. H., and Varma, S. D. Attenuation of sugar cataract by ethyl pyruvate. Mol.Cell Biochem. 1999;200(1-2):103-109.
Morrison, M. A., Spriet, L. L., and Dyck, D. J. Pyruvate ingestion for 7 days does not improve aerobic performance in well-trained individuals. J Appl Physiol 2000;89(2):549-556.
Petkova, I., Mateva, L., Beniozef, D., Petrov, K., and Thorn, W. Sodium pyruvate infusions in patients with alcoholic liver disease. Preliminary report. Acta Physiol Pharmacol.Bulg. 2000;25(3-4):103-108.
Mallet, R. T., Squires, J. E., Bhatia, S., and Sun, J. Pyruvate restores contractile function and antioxidant defenses of hydrogen peroxide-challenged myocardium. J Mol.Cell Cardiol. 2002;34(9):1173-1184.
Stanko, R. T., Reynolds, H. R., Lonchar, K. D., and Arch, J. E. Plasma lipid concentrations in hyperlipidemic patients consuming a high-fat diet supplemented with pyruvate for 6 wk. Am J Clin Nutr 1992;56(5):950-954.
Sappington, P. L., Fink, M. E., Yang, R., Delude, R. L., and Fink, M. P. Ethyl pyruvate provides durable protection against inflammation-induced intestinal epithelial barrier dysfunction. Shock 2003;20(6):521-528.
Olivencia-Yurvati, A. H., Blair, J. L., Baig, M., and Mallet, R. T. Pyruvate-enhanced cardioprotection during surgery with cardiopulmonary bypass. J Cardiothorac.Vasc.Anesth. 2003;17(6):715-720.
Hermann, H. P., Arp, J., Pieske, B., Kogler, H., Baron, S., Janssen, P. M., and Hasenfuss, G. Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure. Eur.J Heart Fail. 3-1-2004;6(2):213-218.
Fink, M. P. Ethyl pyruvate: a novel treatment for sepsis and shock. Minerva Anestesiol. 2004;70(5):365-371.
Gendviliene, V., Zablockaite, D., Babusyte, A., Jurevicius, J., and Benetis, R. [Effect of pyruvate on the dependence of electromechanical activity on stimulation frequency in human myocardium]. Medicina (Kaunas.) 2004;40(11):1097-1104.
Knott, E. M., Ryou, M. G., Sun, J., Heymann, A., Sharma, A. B., Lei, Y., Baig, M., Mallet, R. T., and Olivencia-Yurvati, A. H. Pyruvate-fortified cardioplegia suppresses oxidative stress and enhances phosphorylation potential of arrested myocardium. Am J Physiol Heart Circ.Physiol 2005;289(3):H1123-H1130.
Mallet, R. T., Sun, J., Knott, E. M., Sharma, A. B., and Olivencia-Yurvati, A. H. Metabolic cardioprotection by pyruvate: recent progress. Exp.Biol Med (Maywood.) 2005;230(7):435-443.
Sharma, A. B., Knott, E. M., Bi, J., Martinez, R. R., Sun, J., and Mallet, R. T. Pyruvate improves cardiac electromechanical and metabolic recovery from cardiopulmonary arrest and resuscitation. Resuscitation 2005;66(1):71-81.
Knott, E. M., Sun, J., Lei, Y., Ryou, M. G., Olivencia-Yurvati, A. H., and Mallet, R. T. Pyruvate mitigates oxidative stress during reperfusion of cardioplegia-arrested myocardium. Ann.Thorac.Surg. 2006;81(3):928-934.
Sharma, A. B., Sun, J., Howard, L. L., Williams, A. G., Jr., and Mallet, R. T. Oxidative stress reversibly inactivates myocardial enzymes during cardiac arrest. Am J Physiol Heart Circ.Physiol 2007;292(1):H198-H206.
Fink, M. P. Ethyl pyruvate: a novel treatment for sepsis. Novartis.Found.Symp. 2007;280:147-156.
Fink, M. P. Ethyl pyruvate: a novel treatment for sepsis. Curr.Drug Targets. 2007;8(4):515-518.
Fink, M. P. Ethyl pyruvate. Curr.Opin.Anaesthesiol. 2008;21(2):160-167.
Votto, J. J., Bowen, J. B., Barton, R. W., and Thrall, R. S. Inhaled sodium pyruvate improved FEV1 and decreased expired breath levels of nitric oxide in patients with chronic obstructive pulmonary disease. J Aerosol Med Pulm.Drug Deliv. 2008;21(4):329-334.
Chandra, P., Hegde, K. R., and Varma, S. D. Possibility of topical antioxidant treatment of cataracts: corneal penetration of pyruvate in humans. Ophthalmologica 2009;223(2):136-138.
Kalariya, N. M., Reddy, A. B., Ansari, N. H., Vankuijk, F. J., and Ramana, K. V. Preventive Effects of Ethyl Pyruvate on Endotoxin-induced Uveitis in Rats. Invest Ophthalmol.Vis.Sci. 5-6-2011;
Levy, S. B. and Goldsmith, L. A. Sodium pyruvate treatment for hyperkeratotic disorders. South.Med.J. 1979;72(3):307-310.
Onakpoya I, Hunt K, Wider B, Ernst E. Pyruvate supplementation for weight loss: a systematic review and meta-analysis of randomized clinical trials. Crit Rev Food Sci Nutr. 2014;54(1):17-23.
Ostojic SM, Ahmetovic Z. The effect of 4 weeks treatment with a 2-gram daily dose of pyruvate on body composition in healthy trained men. Int J Vitam Nutr Res. 2009;79(3):173-9.
De Moraes CG, John SWM, Williams PA, Blumberg DM, Cioffi GA, Liebmann JM. Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial. JAMA Ophthalmol 2022;140(1):11-18.
Chilicka K, Rogowska AM, Szygula R, Dziendziora-Urbinska I, Taradaj J. A comparison of the effectiveness of azelaic and pyruvic acid peels in the treatment of female adult acne: a randomized controlled trial. Sci Rep 2020;10(1):12612.
Yang YP, Qiu JQ, Wang MY, et al. Effects of sodium pyruvate supplementation on repeated sprint exercise performance and recovery in male college soccer players: a randomized controlled trial. Ann Palliat Med 2022;11(2):598-610.
Solanki B, Relhan V, Sahoo B, Sarkar R, Choudhary P. Microneedling in Combination With 15% Trichloroacetic Acid Peel Versus 25% Pyruvic Acid Peel in the Treatment of Acne Scars. Dermatol Surg 2023;49(2):155-160.